The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury
Abstract
Fractalkine (FKN), also known as neurotactin, is a CX(3)C chemokine that exists in both secreted and neuronal membrane-bound forms and is upregulated during brain inflammation. There is accumulating evidence that FKN induces chemotaxis by binding to its receptor CX(3)CR1 on leukocytes and microglia. We generated FKN-deficient mice to study the role of FKN in postischemic brain injury. After transient focal cerebral ischemia, FKN-deficient mice had a 28% reduction in infarction size and lower mortality rate, when compared to wild-type littermates. The findings of this study indicate a possible role for FKN in augmenting postischemic injury and mortality after transient focal cerebral ischemia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast , CX3CR1 deficiency ameliorates pathology in murine stroke models.”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [20]
In the citing paper
“Indeed, the effect of CX3CR1 deficiency appears to depend on the nature of the CNS insult as recent studies demonstrated that Cx3cr1 knockout mice exhibit smaller infarcts after transient middle cerebral artery occlusion.19,20”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [20]
In the citing paper
“Indeed, the effect of CX3CR1 deficiency appears to depend on the nature of the CNS insult as recent studies demonstrated that Cx3cr1 knockout mice exhibit smaller infarcts after transient middle cerebral artery occlusion.19,20”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [20]
Citations
Cites
Jung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632
Traffic Signals on Endothelium for Lymphocyte Recirculation and Leukocyte Emigration
Springer, T. A. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.004143 · Cited by 1,497
Imai, T., Hieshima, K., Haskell, C. A., Baba, M., Nagira, M., Nishimura, M., Kakizaki, M., Takagi, S., Nomiyama, H., Schall, T. J., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80438-9 · Cited by 1,472
Harrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., Streit, W. J., Salafranca, M. N., Adhikari, S., Thompson, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10896 · Cited by 1,176
Fong, A. M., Robinson, L. A., Steeber, D. A., Tedder, T. F., Yoshie, O., Imai, T., & Patel, D. D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.8.1413 · Cited by 696
Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation
Pan, Y., Lloyd, C. M., Zhou, H., Dolich, S., Deeds, J., Gonzalo, J.-Á., Vath, J., Gosselin, M., Ma, J., Dussault, B. J., et al. (1997) · Nature · doi:10.1038/42491 · Cited by 643
Self-citationFunctional and structural diversity of the human Dickkopf gene family
Krupnik, V. E., Sharp, J., Jiang, C., Robison, K. E., Chickering, T. W., Amaravadi, L. S., Brown, D. E., Guyot, D. J., Mays, G. G., Leiby, K. R., et al. (1999) · Gene · doi:10.1016/s0378-1119(99)00365-0 · Cited by 491
Self-citationNishiyori, A., Minami, M., Ohtani, Y., Takami, S., Yamamoto, J., Kawaguchi, N., Kume, T., Akaike, A., & Satoh, M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00583-3 · Cited by 365
Chapman, G. A., Moores, K., Harrison, D. C., Campbell, C. A., Stewart, B. R., & Strijbos, P. J. L. M. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-15-j0004.2000 · Cited by 350
Huang, X., Wu, J. F., Cass, D. L., Erle, D. J., Corry, D. B., Young, S. G., Farese, R. V., & Sheppard, D. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.133.4.921 · Cited by 316
Cited by
Sorted by citations
Items 101–200 of 222
Investigational anti-inflammatory agents for the treatment of ischaemic brain injury
Wang, X. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.4.393 · Cited by 59
Neuronal Loss after Stroke Due to Microglial Phagocytosis of Stressed Neurons
Brown, G. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413442 · Cited by 60
Wang, H. K., Park, U. J., Kim, S. Y., Lee, J. H., Kim, S. U., Gwag, B. J., & Lee, Y. B. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4973-07.2008 · Cited by 55
O’Sullivan, S. A., Gasparini, F., Mir, A. K., & Dev, K. K. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0659-7 · Cited by 56
Rancan, M., Bye, N., Otto, V. I., Trentz, O., Kossmann, T., Frentzel, S., & Morganti-Kossmann, M. C. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000133470.91843.72 · Cited by 54
Higher Plasma Fractalkine Is Associated With Better 6-Month Outcome From Ischemic Stroke
Donohue, M. M., Cain, K., Zierath, D., Shibata, D., Tanzi, P. M., & Becker, K. J. (2012) · Stroke · doi:10.1161/strokeaha.112.657411 · Cited by 53
Potential Future Neuroprotective Therapies for Neurodegenerative Disorders and Stroke
Tarawneh, R. M., & Galvin, J. E. (2010) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2009.12.003 · Cited by 54
Chemokines and Their Receptors in Central Nervous System Disease
Biber, K. P. H., de Jong, E., van Weering, H. R. J., & Boddeke, H. W. G. M. (2006) · Current Drug Targets · doi:10.2174/138945006775270196 · Cited by 52
Hernandez, V. G., Lechtenberg, K. J., Peterson, T. C., Zhu, L., Lucas, T. A., Bradshaw, K. P., Owah, J. O., Dorsey, A. I., Gentles, A. J., & Buckwalter, M. S. (2023) · Glia · doi:10.1002/glia.24377 · Cited by 51
NAVIA, B. A., & Rostasy, K. M. (2005) · Neurotoxicity Research · doi:10.1007/bf03033817 · Cited by 51
CCR6: A Biomarker for Alzheimer's-like Disease in a Triple Transgenic Mouse Model
Subramanian, S., Ayala, P., Wadsworth, T. L., Harris, C., Vandenbark, A. A., Quinn, J. F., & Offner, H. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100852 · Cited by 50
CNS Immune Responses Following Experimental Stroke
Zierath, D. K., Thullbery, M., Hadwin, J., Gee, J. M., Savos, A. V., Kalil, A., & Becker, K. J. (2009) · Neurocritical Care · doi:10.1007/s12028-009-9270-4 · Cited by 48
Glucocorticoid signaling in myeloid cells worsens acute CNS injury and inflammation
Sorrells, S. F., Caso, J. R., Munhoz, C. D., Hu, C. K., Tran, K. V., Miguel, Z. D., Chien, B. Y., & Sapolsky, R. M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4705-12.2013 · Cited by 46
Brandi, E., Torres-Garcia, L., Svanbergsson, A., Haikal, C., Liu, D., Li, W., & Li, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.910988 · Cited by 48
CX3CL1 protects neurons against excitotoxicity enhancing GLT-1 activity on astrocytes
Catalano, M., Lauro, C., Cipriani, R., Chece, G., Ponzetta, A., Angelantonio, S. D., Ragozzino, D., & Limatola, C. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.07.020 · Cited by 44
Cognitive impairment in heart failure: A protective role for angiotensin-(1-7).
Hay, M., Vanderah, T. W., Samareh-Jahani, F., Constantopoulos, E., Uprety, A. R., Barnes, C. A., & Konhilas, J. P. (2017) · Behavioral Neuroscience · doi:10.1037/bne0000182 · Cited by 43
Xiang, Y., Zhao, H., Wang, J., Zhang, L., Liu, A., & Chen, Y. (2016) · Biomedical Reports · doi:10.3892/br.2016.677 · Cited by 42
Zhu, J., Zhou, Z., Liu, Y., & Zheng, J. (2009) · Brain Research · doi:10.1016/j.brainres.2009.06.068 · Cited by 40
Expression of chemokine-like factor 1 after focal cerebral ischemia in the rat
Kong, L., Hu, J., Zhang, W., Yuan, Y., Ma, K., Han, N., & Chen, N. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.09.031 · Cited by 38
Cai, Y., Cho, G., Ju, C., Wang, S.-L., Ryu, J. H., Shin, C. Y., Kim, H.-S., Nam, K.-W., Jalin, A. M. A. A., Sun, W., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002925 · Cited by 39
The role of microglia in ischemic preconditioning
McDonough, A., & Weinstein, J. R. (2019) · Glia · doi:10.1002/glia.23695 · Cited by 39
Zhang, D., Stumpo, D. J., Graves, J. P., DeGraff, L. M., Grissom, S. F., Collins, J. B., Li, L., Zeldin, D. C., & Blackshear, P. J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03930.x · Cited by 37
Hydrogel-mediated drug delivery for treating stroke
Yu, W., Gong, E., Liu, B., Zhou, L., Che, C., Hu, S., Zhang, Z., Liu, J., & Shi, J. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2023.108205 · Cited by 37
Two Novel Fully Functional Isoforms of CX3CR1 Are Potent HIV Coreceptors
Garin, A., Tarantino, N., Faure, S., Daoudi, M., Lécureuil, C., Bourdais, A., Debré, P., Déterre, P., & Combadière, C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5305 · Cited by 39
Chemokine receptors as important regulators of pathogenesis during arboviral encephalitis
Michlmayr, D., & Lim, J. K. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00264 · Cited by 38
Aggravated experimental autoimmune encephalomyelitis in IL-15 knockout mice
Gómez‐Nicola, D., Spagnolo, A., Guaza, C., & Nieto‐Sampedro, M. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2009.12.034 · Cited by 35
Briones, T. L., Woods, J., & Wadowska, M. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-13 · Cited by 35
RetractedCloning and functional characterization of the human fractalkine receptor promoter regions
Garin, A., Pellet, P., Déterre, P., Debré, P., & Combadière, C. (2002) · Biochemical Journal · doi:10.1042/bj20020951 · Cited by 35
Langer, R., Wang, M., Stepkowski, S. M., Hancock, W. W., Han, R., Li, P., Feng, L., Kirken, R. A., Berens, K. L., Dupré, B., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000142425.23036.ac · Cited by 33
Chen, M., Luo, C., Peñalva, R. G., & Xu, H. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10888 · Cited by 33
Zhang, D., Harry, G. J., Blackshear, P. J., & Zeldin, D. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708209200 · Cited by 32
Dagkalis, A., Wallace, C. A., Hing, B. W. Q., Liversidge, J., & Crane, I. J. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03046.x · Cited by 32
The CX 3 C Chemokine Fractalkine Induces Vascular Dysfunction by Generation of Superoxide Anions
Schäfer, A., Schulz, C., Fraccarollo, D., Tas, P. W. L., Leutke, M., Eigenthaler, M., Seidl, S., Heider, P., Ertl, G., Maßberg, S., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000251535.30191.60 · Cited by 35
Wu, X., Liu, Y. U., Qian, Z., Luo, Q., & Ke, Y. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9339-3 · Cited by 32
Plasma interleukin-1β concentration is associated with stroke in sickle cell disease
Asare, K., Gee, B. E., Stiles, J. K., Wilson, N. O., Driss, A., Quarshie, A., Adams, R. J., Kutlar, A., & Hibbert, J. M. (2009) · Cytokine · doi:10.1016/j.cyto.2009.10.002 · Cited by 31
Michalettos, G., & Ruscher, K. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.807911 · Cited by 31
Monocytes in Sterile Inflammation: Recruitment and Functional Consequences
Spahn, J. H., & Kreisel, D. (2013) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-013-0267-5 · Cited by 30
Annamneedi, A., Gora, C., Dudas, A., Leray, X., Bozon, V., Crépieux, P., & Pellissier, L. P. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16216 · Cited by 29
Interaction of microglia with the microenvironment in spinal cord injury
Timofeeva, A. V., Akhmetzyanova, E. R., Rizvanov, A. A., & Mukhamedshina, Y. O. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.11.074 · Cited by 29
Wong, S. Y., Tan, M. G. K., Banks, W. A., Wong, W. S. F., Wong, P. T. ‐., & Lai, M. K. P. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0498-6 · Cited by 27
Genetic neutrophil deficiency ameliorates cerebral ischemia-reperfusion injury
Frieler, R. A., Chung, Y., Ahlers, C. G., Gheordunescu, G., Song, J., Vigil, T. M., Shah, Y. M., & Mortensen, R. M. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.08.016 · Cited by 29
Fractalkine – a local inflammatory marker aggravating platelet activation at the vulnerable plaque
Flierl, U., & Schäfer, A. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-04-0271 · Cited by 26
Denoyer, A., Godefroy, D., Célérier, I., Frugier, J., Riancho, L., Brignole‐Baudouin, F., Rostène, W. H., & Baudouin, C. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.43 · Cited by 26
Große, G. M., Tryc, A. B., Dirks, M., Schuppner, R., Pflugrad, H., Lichtinghagen, R., Weißenborn, K., & Worthmann, H. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-74 · Cited by 26
Neuro-Immune Crosstalk in CNS Diseases
Kerschensteiner, M., Meinl, E., & Hohlfeld, R. (2009) · Results and problems in cell differentiation · doi:10.1007/400_2009_6 · Cited by 26
Kong, L., Hu, J., Zhang, W., Yuan, Y., Han, N., & Chen, N. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.11.048 · Cited by 25
Du, B., Liang, M., Zheng, H., Fan, C., Zhang, H., Lu, X., Du, Z., Lian, Y., Zhang, Y., & Bi, X. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.05.011 · Cited by 26
Kwiecień, J. M., Jarosz, B., Urdzíková, L. M., Rola, R., & Dąbrowski, W. (2015) · Folia Neuropathologica · doi:10.5114/fn.2015.49973 · Cited by 26
Cuenca-López, M. D., Brea, D., Segura, T., Galindo, M. F., Martinez, D., Freire, J. A., Castillo, J., & Bueso, J. J. (2010) · Revista de Neurología · doi:10.33588/rn.5006.2009666 · Cited by 24
Autism spectrum disorders and natural killer cells: a review on pathogenesis and treatment
Meimand, S. E., Abadi, Y. R., & Rezaei, N. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2020.1850273 · Cited by 25
CX3CR1 + Macrophage Facilitates the Resolution of Allergic Lung Inflammation via Interacting CCL26
Moon, H., Kim, S.-J., Kim, K.-H., Kim, Y.-M., Rehman, J., Lee, H., Wu, Y.-C., Lee, S. Y., Christman, J. W., Ackerman, S. J., et al. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202209-1670oc · Cited by 22
Cell-to-Cell Interactions Mediating Functional Recovery after Stroke
Alia, C., Cangi, D., Massa, V., Salluzzo, M., Vignozzi, L., Caleo, M., & Spalletti, C. (2021) · Cells · doi:10.3390/cells10113050 · Cited by 24
Hurst, L. A., Bunning, R. A. D., Couraud, P., Romero, I. A., Weksler, B. B., Sharrack, B., & Woodroofe, M. N. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.02.008 · Cited by 22
Role of the chemokine receptors CCR2 and CX3CR1 in an experimental model of thrombotic stroke
Cisbani, G., Béhot, A. L., Plante, M.-M., Préfontaine, P., Lecordier, M., & Rivest, S. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.03.008 · Cited by 23
Iron Pathophysiology in Stroke
Almutairi, M. M., Xu, G., & Shi, H. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9589-5_6 · Cited by 21
Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis
Stochmal, A., Czuwara, J., Zaremba, M., & Rudnicka, L. (2019) · Archives of Dermatological Research · doi:10.1007/s00403-019-01993-y · Cited by 21
CX3CR1 deficiency leads to impairment of immune surveillance in the epididymis
Barrachina, F., Ottino, K., Tu, L. J., Soberman, R. J., Brown, D., Breton, S., & Battistone, M. A. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04664-w · Cited by 19
Targeting foam cell formation to improve recovery from ischemic stroke
Zbesko, J. C., Stokes, J., Becktel, D. A., & Doyle, K. P. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106130 · Cited by 19
Increased serum fractalkine in systemic sclerosis. Down-regulation by prostaglandin E1.
Sicińska, J., Górska, E., Cicha, M., Kuklo-Kowalska, A., Hamze, V., Stepien, K., Wąsik, M., & Rudnicka, L. (2008) · PubMed · Cited by 18
Zhang, X., Wei, H., Wang, H., & Tian, Z. (2006) · Oncology Reports · doi:10.3892/or.15.2.485 · Cited by 17
The chemokine fractalkine (CX3CL1) attenuates H2O2-induced demyelination in cerebellar slices
O’Sullivan, S. A., & Dev, K. K. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0932-4 · Cited by 17
Ahn, J., Kim, D., Park, J. H., Lee, T., Lee, H., Won, M., & Lee, C. H. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4273 · Cited by 16
Ji, J. F., Dheen, S. T., Srinivasan, D. K., He, B., & Tay, S. S. W. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.09.017 · Cited by 16
Chen, Y., Green, S. R., Almazan, F., & Quehenberger, O. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.015909 · Cited by 19
Li, Z., Cao, X., Ma, H., Cui, Y., Li, X., Wang, N., & Zhou, Y. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly051 · Cited by 15
Menasria, R., Canivet, C., Piret, J., Gosselin, J., & Boivin, G. (2016) · Journal of General Virology · doi:10.1099/jgv.0.000667 · Cited by 16
Fractalkine: a novel cardiac chemokine?
Altin, S. E., & Schulze, P. C. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr272 · Cited by 14
Chemokine CX3CL1 (Fractalkine) Signaling and Diabetic Encephalopathy
Wątroba, M., Grabowska, A. D., & Szukiewicz, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147527 · Cited by 13
Lee, J., Ahn, J. H., Kim, I. H., Park, J. H., Yan, B. C., Cho, G., Ohk, T. G., Park, C. W., Cho, J. H., Kim, Y., et al. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.10.041 · Cited by 11
Schäfer, A., Widder, J. D., Eigenthaler, M., Ertl, G., & Bauersachs, J. K. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.02.034 · Cited by 11
Marcondes, M. C. G., Ojakian, R., Bortell, N., Flynn, C. T., Conti, B., & Fox, H. S. (2014) · Mediators of Inflammation · doi:10.1155/2014/358218 · Cited by 12
Expression of Fractalkine (CX3CL1) and Its Receptor in Endotoxin-Induced Uveitis
Chu, L., Li, X., Yu, W., Qian, T., Qi, H., Huang, L., & Xu, Y. (2009) · Ophthalmic Research · doi:10.1159/000230878 · Cited by 11
Cipriani, R., Domerq, M., Martín, A., & Matute, C. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_23 · Cited by 10
Regulators of phagocytosis as pharmacologic targets for stroke treatment
Cheng, J. G., Wang, W., Xia, Y., Li, Y., Jia, J., & Xiao, G. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1122527 · Cited by 10
Chen, H., Li, S., Xu, W., Hong, Y., Dou, R., Shen, H., Liu, X., Wu, T., & He, J. C. (2020) · Tissue and Cell · doi:10.1016/j.tice.2020.101482 · Cited by 10
Neuro-glio-vascular Interaction in Ischemic Brains
Minami, M. (2011) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.131.539 · Cited by 10
Inflammation, Oxidative Stress, and Cerebral Stroke: Basic Principles
Tiwari, S. K., Mishra, P., & Rajavashisth, T. B. (2019) · Springer eBooks · doi:10.1007/978-981-13-1453-7_2 · Cited by 9
Role of Chemokines in Ischemic Neuronal Stress
Minami, M., & Satoh, M. (2005) · NeuroMolecular Medicine · doi:10.1385/nmm:7:1-2:149 · Cited by 9
Microglial Inflammatory Mechanisms in Stroke: The Jury Is Still Out
Benkő, S., & Dénes, Á. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.02.007 · Cited by 9
Li, Q., Luo, S., Wang, F., Zhen, J., Sun, H.-B., & Guo, C. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.05.044 · Cited by 6
Fractalkine receptor polymorphism and chronic tonsillitis
Babakurban, S. T., Erbek, S. S., Terzi, Y. K., Arslan, F., & Şahin, F. İ. (2014) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-014-2908-7 · Cited by 6
Characterization of human cortical gene expression in relation to glucose utilization
Sterner, K. N., McGowen, M. R., Chugani, H. T., Tarca, A. L., Sherwood, C. C., Hof, P. R., Kuzawa, C. W., Boddy, A. M., Raaum, R. L., Weckle, A. L., et al. (2013) · American Journal of Human Biology · doi:10.1002/ajhb.22394 · Cited by 6
Inflammation et lésions cérébrales aiguës en anesthésie réanimation
Degos, V., Teissier, N., Gressèns, P., Puybasset, L., & Mantz, J. (2008) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/j.annfar.2008.07.099 · Cited by 5
Chemokine Receptors in Neuroinflammation
Cardona, A. E., & Ransohoff, R. M. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-020-1_17 · Cited by 5
Cytokines and Chemokines in Stroke
Ballesteros, I., Cuartero, M. I., Pradillo, J. M., Moro, M. Á., & Lizasoaín, I. (2017) · Primer on Cerebrovascular Diseases · doi:10.1016/b978-0-12-803058-5.00058-8 · Cited by 5
Michalettos, G., Walter, H. L., Antunes, A. R. P., Wieloch, T. W., Talhada, D., & Ruscher, K. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02510-x · Cited by 4
Chemokines as Plurifunctional Mediators in the CNS: Implications for the Pathogenesis of Stroke
Campbell, I. L. (2004) · Springer eBooks · doi:10.1007/978-3-662-05403-1_3 · Cited by 4
Modeling Risk Factors and Confounding Effects in Stroke
McColl, B., Howells, D., Rothwell, N., & Denes, A. (2010) · Neuromethods · doi:10.1007/978-1-60761-750-1_9 · Cited by 3
Briones, T. L., Woods, J., & Wadowska, M. (2014) · The FASEB Journal · doi:10.1096/fasebj.28.1_supplement.877.1 · Cited by 3
Modeling Risk Factors and Confounding Effects in Stroke
McColl, B. W., Howells, D. W., Rothwell, N. J., & Dénes, Á. (2016) · Neuromethods · doi:10.1007/978-1-4939-5620-3_9 · Cited by 3
MerTK and the Role of Phagoptosis in Neonatal Hypoxia-Ischemia
Jonsdotter, A., Hagberg, H., Leverin, A., Ek, C. J., Ebefors, K., Rocha‐Ferreira, E., & Carlsson, Y. (2025) · Cells · doi:10.3390/cells14231862 · Cited by 2
Bosshart, S. L., Fernández-Vega, A., Kaufmann, J. E., Stebner, A., Tiedt, S., Montaner, J., Ospel, J. M., & Große, G. M. (2026) · Stroke · doi:10.1161/strokeaha.125.051472 · Cited by 2
Liu, Z.-X., Wang, X., Haghparast, A., He, W., & Zhang, J. (2023) · Brain Behavior and Immunity Integrative · doi:10.1016/j.bbii.2023.100025 · Cited by 2
The Association of Plasma Fractalkine and Inflammation After Ischemic Stroke
Herminawati, L., Wijaya, A., Arief, M., & As’ád, S. (2016) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v8i2.205 · Cited by 2
Briones, T. L., Woods, J., & Wadowska, M. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0442-1 · Cited by 2
RetractedHafermehl, K. T. (2016) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3p84416b · Cited by 2
Racial/ethnic variations in acute stroke
Gezmu, T. (2012) · Rutgers University Community Repository (Rutgers University) · doi:10.7282/t38p5zfs · Cited by 2
Acute and Long-Term Consequences of Neonatal NMDA Blockade in the Cx3cr1 Knock-Out Mouse
Salcido, F. A. M., Torres-Flores, M. I., Ordaz, B., & Peña‐Ortega, F. (2025) · Inflammation · doi:10.1007/s10753-025-02272-x · Cited by 1
Effect of Fractalkine Signaling on Neuroinflammation and Neuropathic Pain–like Behavior in Mice
Fan, Q., Kim, J., Zhang, J., Zhang, Q., Hwang, M., Li, J., Li, F., Yin, Y., Han, Y., Shah, K., et al. (2026) · Anesthesiology · doi:10.1097/aln.0000000000006257 · Cited by 1
Lipoic Acid, Inflammation and Diseases of the Nervous System
Carr, D. W., & Salinthone, S. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_86 · Cited by 1
Metadata
- Authors
- Soriano, S. G., Amaravadi, L. S., Wang, Y. F., Zhou, H., Yu, G. X., Tonra, J. R., Fairchild-Huntress, V., Fang, Q., Dunmore, J. H., Huszar, D., & Pan, Y.
- Affiliations
- Boston Children's Hospital (US)
- Takeda Oncology (United States) (US)
- Corresponding author
- Soriano, Sulpicio G.
- Venue
- Journal of Neuroimmunology
- Publisher
- Elsevier BV
- Published
- 2002-04
- Volume
- 125
- Issue
- 1-2
- Pages
- 59-65
- ISSN
- 0165-5728 (ISSN-L)
- OpenAlex
- W2077196241
- Cited by
- 222
- References
- 20
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 5 · 2023: 7 · 2022: 4 · 2021: 6 · 2020: 6 · 2019: 8 · 2018: 4 · 2017: 8 · 2016: 11 · 2015: 15 · 2014: 15 · 2013: 13 · 2012: 10
- FWCI
- 5.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neuroimmunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- fractalkine, CX3C chemokines, CX3CR1, transient focal cerebral ischemia, ischemia-reperfusion injury, infarct size, neuroprotection, chemokine receptors, neuroinflammation, microglia
- MeSH terms
- Animals, Ischemic Attack, Transient, Disease Susceptibility, Membrane Proteins, Mice, Inbred BALB C, RNA, Messenger, Reperfusion Injury, Gene Expression, Mice, Knockout, Infarction, Middle Cerebral Artery, Chemokines, CX3C, Mice, Chemokine CX3CL1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review